BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Macquarie maintains outperform on Strides Shasun
Successful inspection by US drug regulator bodes well for Strides. USFDA approval crucial going ahead. Strides is one of our top picks. We are positive on Sun Pharma and Glenmark as well.